Cholesterol emboli syndrome natural history, complications and prognosis

Cholesterol emboli syndrome Microchapters
Home
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Cholesterol emboli syndrome from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Cholesterol emboli syndrome natural history, complications and prognosis On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Cholesterol emboli syndrome natural history, complications and prognosis All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Cholesterol emboli syndrome natural history, complications and prognosis
CDC on Cholesterol emboli syndrome natural history, complications and prognosis
Cholesterol emboli syndrome natural history, complications and prognosis in the news
Blogs on Cholesterol emboli syndrome natural history, complications and prognosis
Directions to Hospitals Treating Cholesterol emboli syndrome
Risk calculators and risk factors for Cholesterol emboli syndrome natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Natural History, Complications and Prognosis

• Many patients go on to amputation, renal failure, other organ system failure, and/or death.
• Mortality has not been well studied. The diagnosis may be difficult to make, and requires suspicion based upon clinical findings that often mimic other diseases. Therefore, the correct diagnosis is often never made, so the natural history and prognosis of all patients with CES is difficult to ascertain.
• Nevertheless, mortality been reported to be as high as 37-90%, biased by selection and report bias.
• Given the pathogenesis, one would expect a spectrum of disease, with probably significant numbers of subclinical, good prognosis patients.

References

Template:WikiDoc Sources